Human receptor for activated protein kinase C1 associates with polyglutamine aggregates and modulates polyglutamine toxicity

Biochemical and Biophysical Research Communications

Volumn 377, Issue 2, 2008, Pages 714-719

  Lam, Wun ^a   Chan, Wing Man ^a   Lo, Tsz Wai ^a   Wong, Azaria Kam Yan ^a   Wu, Chi Chung ^a   Chan, Ho Yin Edwin ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Drosophila; Machado Joseph Disease; RACK1; WD domain

Indexed keywords

POLYGLUTAMINE; RECEPTOR FOR ACTIVATED C KINASE 1;

ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; DROSOPHILA; HUMAN; HUMAN CELL; NERVE DEGENERATION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEOMICS;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; DISEASE MODELS, ANIMAL; DROSOPHILA MELANOGASTER; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FORMIC ACIDS; GTP-BINDING PROTEINS; HEREDODEGENERATIVE DISORDERS, NERVOUS SYSTEM; HUMANS; NEOPLASM PROTEINS; PEPTIDES; PROTEIN STRUCTURE, TERTIARY; PROTEOMICS; RECEPTORS, CELL SURFACE;

EID: 55549136367     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.10.057     Document Type: Article

References (42)

1. Zoghbi H.Y., and Orr H.T. Glutamine repeats and neurodegeneration. Annu. Rev. Neurosci. 23 (2000) 217-247
2. Orr H.T., and Zoghbi H.Y. Trinucleotide repeat disorders. Annu. Rev. Neurosci. 30 (2007) 575-621
3. Sittler A., Walter S., Wedemeyer N., Hasenbank R., Scherzinger E., Eickhoff H., Bates G.P., Lehrach H., and Wanker E.E. SH3GL3 associates with the Huntingtin exon 1 protein and promotes the formation of polygln-containing protein aggregates. Mol. Cell 2 (1998) 427-436
4. Ross C.A., and Poirier M.A. Protein aggregation and neurodegenerative disease. Nat. Med. 10 Suppl (2004) S10-S17
5. Doi H., Mitsui K., Kurosawa M., Machida Y., Kuroiwa Y., and Nukina N. Identification of ubiquitin-interacting proteins in purified polyglutamine aggregates. FEBS Lett. 571 (2004) 171-176
6. Hazeki N., Tsukamoto T., Yazawa I., Koyama M., Hattori S., Someki I., Iwatsubo T., Nakamura K., Goto J., and Kanazawa I. Ultrastructure of nuclear aggregates formed by expressing an expanded polyglutamine. Biochem. Biophys. Res. Commun. 294 (2002) 429-440
7. Mitsui K., Doi H., and Nukina N. Proteomics of polyglutamine aggregates. Methods Enzymol. 412 (2006) 63-76
8. Suhr S.T., Senut M.C., Whitelegge J.P., Faull K.F., Cuizon D.B., and Gage F.H. Identities of sequestered proteins in aggregates from cells with induced polyglutamine expression. J. Cell Biol. 153 (2001) 283-294
9. Perluigi M., Poon H.F., Maragos W., Pierce W.M., Klein J.B., Calabrese V., Cini C., De Marco C., and Butterfield D.A. Proteomic analysis of protein expression and oxidative modification in r6/2 transgenic mice. a model of Huntington disease. Mol. Cell. Proteomics 4 (2005) 1849-1861
10. Qi M.L., Tagawa K., Enokido Y., Yoshimura N., Wada Y., Watase K., Ishiura S., Kanazawa I., Botas J., Saitoe M., Wanker E.E., and Okazawa H. Proteome analysis of soluble nuclear proteins reveals that HMGB1/2 suppress genotoxic stress in polyglutamine diseases. Nat. Cell Biol. 9 (2007) 402-414
11. Chiang M.C., Juo C.G., Chang H.H., Chen H.M., Yi E.C., and Chern Y. Systematic uncovering of multiple pathways underlying the pathology of Huntington disease by an acid-cleavable isotope-coded affinity tag approach. Mol. Cell. Proteomics 6 (2007) 781-797
12. Zabel C., Chamrad D.C., Priller J., Woodman B., Meyer H.E., Bates G.P., and Klose J. Alterations in the mouse and human proteome caused by Huntington's disease. Mol. Cell. Proteomics 1 (2002) 366-375
13. Chan H.Y., Warrick J.M., Andriola I., Merry D., and Bonini N.M. Genetic modulation of polyglutamine toxicity by protein conjugation pathways in Drosophila. Hum. Mol. Genet. 11 (2002) 2895-2904
14. Chan H.Y., Warrick J.M., Gray-Board G.L., Paulson H.L., and Bonini N.M. Mechanisms of chaperone suppression of polyglutamine disease: selectivity, synergy and modulation of protein solubility in Drosophila. Hum. Mol. Genet. 9 (2000) 2811-2820
15. Dehay B., and Bertolotti A. Critical role of the proline-rich region in Huntingtin for aggregation and cytotoxicity in yeast. J. Biol. Chem. 281 (2006) 35608-35615
16. Hazeki N., Tukamoto T., Goto J., and Kanazawa I. Formic acid dissolves aggregates of an N-terminal Huntingtin fragment containing an expanded polyglutamine tract: applying to quantification of protein components of the aggregates. Biochem. Biophys. Res. Commun. 277 (2000) 386-393
17. Hoffner G., Island M.L., and Djian P. Purification of neuronal inclusions of patients with Huntington's disease reveals a broad range of N-terminal fragments of expanded Huntingtin and insoluble polymers. J. Neurochem. 95 (2005) 125-136
18. Iuchi S., Hoffner G., Verbeke P., Djian P., and Green H. Oligomeric and polymeric aggregates formed by proteins containing expanded polyglutamine. Proc. Natl. Acad. Sci. USA 100 (2003) 2409-2414
19. Warrick J.M., Paulson H.L., Gray-Board G.L., Bui Q.T., Fischbeck K.H., Pittman R.N., and Bonini N.M. Expanded polyglutamine protein forms nuclear inclusions and causes neural degeneration in Drosophila. Cell 93 (1998) 939-949
20. McGuire S.E., Le P.T., Osborn A.J., Matsumoto K., and Davis R.L. Spatiotemporal rescue of memory dysfunction in Drosophila. Science 302 (2003) 1765-1768
21. McGuire S.E., Mao Z., and Davis R.L. Spatiotemporal gene expression targeting with the TARGET and gene-switch systems in Drosophila. Sci. STKE 2004 (2004) l6
22. Shiga Y., Tanaka-Matakatsu M., and Hayashi S. A nuclear GFP/ beta-galactosidase fusion protein as a marker for morphogenesis in living Drosophila. Dev. Growth Diff. 38 (1996) 99-106
23. Wong S.L., Chan W.M., and Chan H.Y. Sodium dodecyl sulfate-insoluble oligomers are involved in polyglutamine degeneration. FASEB J. 22 (2008) 3348-3357
24. Wong S.L., Chen Y., Chan C.M., Chan C.S., Chan P.K., Chui Y.L., Fung K.P., Waye M.M., Tsui S.K., and Chan H.Y. In vivo functional characterization of the SARS-Coronavirus 3a protein in Drosophila. Biochem. Biophys. Res. Commun. 337 (2005) 720-729
25. Velazquez J.M., Sonoda S., Bugaisky G., and Lindquist S. Is the major Drosophila heat shock protein present in cells that have not been heat shocked?. J. Cell Biol. 96 (1983) 286-290
26. Lessing D., and Bonini N.M. Polyglutamine genes interact to modulate the severity and progression of neurodegeneration in Drosophila. PLoS Biol. 6 (2008) e29
27. Wanker E.E., Scherzinger E., Heiser V., Sittler A., Eickhoff H., and Lehrach H. Membrane filter assay for detection of amyloid-like polyglutamine-containing protein aggregates. Methods Enzymol. 309 (1999) 375-386
28. Cummings C.J., Mancini M.A., Antalffy B., DeFranco D.B., Orr H.T., and Zoghbi H.Y. Chaperone suppression of aggregation and altered subcellular proteasome localization imply protein misfolding in SCA1. Nat. Genet. 19 (1998) 148-154
29. Warrick J.M., Chan H.Y., Gray-Board G.L., Chai Y., Paulson H.L., and Bonini N.M. Suppression of polyglutamine-mediated neurodegeneration in Drosophila by the molecular chaperone HSP70. Nat. Genet. 23 (1999) 425-428
30. Kim S., Nollen E.A., Kitagawa K., Bindokas V.P., and Morimoto R.I. Polyglutamine protein aggregates are dynamic. Nat. Cell Biol. 4 (2002) 826-831
31. Burke J.R., Enghild J.J., Martin M.E., Jou Y.S., Myers R.M., Roses A.D., Vance J.M., and Strittmatter W.J. Huntingtin and DRPLA proteins selectively interact with the enzyme GAPDH. Nat. Med. 2 (1996) 347-350
32. Koshy B., Matilla T., Burright E.N., Merry D.E., Fischbeck K.H., Orr H.T., and Zoghbi H.Y. Spinocerebellar ataxia type-1 and spinobulbar muscular atrophy gene products interact with glyceraldehyde-3-phosphate dehydrogenase. Hum. Mol. Genet. 5 (1996) 1311-1318
33. Wang Q., Woltjer R.L., Cimino P.J., Pan C., Montine K.S., Zhang J., and Montine T.J. Proteomic analysis of neurofibrillary tangles in Alzheimer disease identifies GAPDH as a detergent-insoluble paired helical filament tau binding protein. FASEB J. 19 (2005) 869-871
34. Vani K., Yang G., and Mohler J. Isolation and cloning of a Drosophila homolog to the mammalian RACK1 gene, implicated in PKC-mediated signalling. Biochim. Biophys. Acta 1358 (1997) 67-71
35. Battaini F., and Pascale A. Protein kinase C signal transduction regulation in physiological and pathological aging. Ann. N Y Acad. Sci. 1057 (2005) 177-192
36. Sklan E.H., Podoly E., and Soreq H. RACK1 has the nerve to act: structure meets function in the nervous system. Prog. Neurobiol. 78 (2006) 117-134
37. Battaini F., Pascale A., Lucchi L., Pasinetti G.M., and Govoni S. Protein kinase C anchoring deficit in postmortem brains of Alzheimer's disease patients. Exp. Neurol. 159 (1999) 559-564
38. Peyrl A., Weitzdoerfer R., Gulesserian T., Fountoulakis M., and Lubec G. Aberrant expression of signaling-related proteins 14-3-3 gamma and RACK1 in fetal Down syndrome brain (Trisomy 21). Electrophoresis 23 (2002) 152-157
39. Wang H., and Friedman E. Increased association of brain protein kinase C with the receptor for activated C kinase-1 (RACK1) in bipolar affective disorder. Biol. Psychiatry 50 (2001) 364-370
40. Mochly-Rosen D., Khaner H., and Lopez J. Identification of intracellular receptor proteins for activated protein kinase C. Proc. Natl. Acad. Sci. USA 88 (1991) 3997-4000
41. Li S., and Li X.J. Multiple pathways contribute to the pathogenesis of Huntington disease. Mol. Neurodegener. 1 (2006) 19
42. Shao J., and Diamond M.I. Polyglutamine diseases: emerging concepts in pathogenesis and therapy. Hum. Mol. Genet. 16 Spec No. 2 (2007) R115-R123